SMTL ID : 9ce4.1

Structure of CHK1 10-pt. mutant complex with LRRK2 indazole inhibitor compound 6

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.31 Å

Oligo State

monomer

Ligands

1 x 01: (1S,4r)-4-[(1P)-5-chloro-1-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-6-yl]-1-(oxetan-3-yl)piperidin-1-ium

01.1: 17 residues within 4Å: Chain A: L.12, G.13, E.14, V.20, A.33, I.65, M.81, E.82, L.83, A.84, S.85, G.87, H.131, N.132, L.134, A.144, D.145 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.20, A:V.20, A:A.33, A:L.134, A:L.134 Hydrogen bonds: A:A.84, A:H.131 Water bridges: A:H.131

7 x EDO: 1,2-ETHANEDIOL

EDO.2: 7 residues within 4Å: Chain A: G.120, I.121, G.122, R.153, Y.154, N.155, N.156 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.120, A:R.153, A:N.156 Water bridges: A:N.155, A:N.155 EDO.3: 3 residues within 4Å: Chain A: R.153, E.158, E.184 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.153, A:E.184 EDO.4: 6 residues within 4Å: Chain A: K.51, C.54, I.55, M.58, V.151, Y.154 No protein-ligand interaction detected (PLIP) EDO.5: 6 residues within 4Å: Chain A: R.92, M.99, P.100, D.103, F.107, D.139 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.92, A:D.103 EDO.6: 4 residues within 4Å: Chain A: T.167, P.169, Y.170, L.203 No protein-ligand interaction detected (PLIP) EDO.7: 7 residues within 4Å: Chain A: F.90, I.93, Y.170, A.197, G.201, E.202, L.203 1 PLIP interactions: 1 interactions with chain A Water bridges: A:L.203 EDO.8: 6 residues within 4Å: Chain A: W.218, K.219, K.221, H.240, L.243, V.244 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:W.218, A:H.240

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Logan, K.M. et al., Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors. J.Med.Chem. (2024)

Release Date

2024-09-18

Peptides

Serine/threonine-protein kinase Chk1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase Chk1